mitoxantrone has been researched along with Chemotherapy-Induced Febrile Neutropenia in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Chemotherapy-Induced Febrile Neutropenia: FEVER accompanied by a significant reduction in NEUTROPHIL count associated with CHEMOTHERAPY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roengvoraphoj, M | 1 |
| Yan, S | 1 |
| Lansigan, F | 1 |
| Chapman, MS | 1 |
| Danilov, AV | 1 |
1 other study available for mitoxantrone and Chemotherapy-Induced Febrile Neutropenia
| Article | Year |
|---|---|
Acute inflammatory skin reaction during neutrophil recovery after antileukemic therapy.
Topics: Adult; Antineoplastic Agents; Chemotherapy-Induced Febrile Neutropenia; Humans; Leukemia, Promyelocy | 2016 |